BioWorld

Nov. 14, 2006

View Archived Issues

Illumina Taking Over Solexa In $660M Stock-Swap Deal

Illumina Inc.'s plan to take over Solexa Inc. in a $600 million stock swap recalls the buyout of CyVera Corp. early last year, which provided Illumina an entry into the diagnostics field. (BioWorld Today) Read More

Favrille Falls On Interim Analysis Of Pivotal FavId Study In NHL

Read More

Research in Gene Expression Leads To Findings In Epilepsy

Read More

HDL-Focused Cerenis Raises $53.5M In Series B Financing

Read More

Other News To Note

Read More

Clinic Roundup

Read More

U.S. Patent Disclosures

Read More